STING1 and cancer: The distribution of cancers with STING immunoexpression/its lack was not significantly correlated with other epidemiological (patient’s age, gender, Karnofsky status, levels of smoking and drinking), clinical (T and N stage) and histopathological features (grade, keratinization status, active HPV16 infection).